Facility
Srivathsa has a well integrated manufacturing facility for intermediate of API’s and Drug Intermediates with a total reactor capacity of around 95 KL along with necessary supporting equipment and utilities.
The manufacturing facility is supported by R & D, Pilot Plant and Quality Control Laboratory, equipped with necessary instruments and facilitate to new products development and ensure close controls of various quality parameters.
